Heme-dependent activation and free radical generation in Plasmodium falciparum

This entry refers to a **biochemical process** in *Plasmodium falciparum*—the heme (and/or ferrous iron)-dependent activation of certain antimalarial drugs (notably artemisinin and derivatives), leading to the formation of toxic free radicals inside the parasite. During the blood stage, *P. falciparum* digests host hemoglobin, releasing heme and iron; artemisinin requires activation by these iron sources (predominantly heme) to generate highly reactive radicals. These radicals cause widespread molecular damage to parasite components, leading to parasite death. The process is central to the mechanism of artemisinin-based therapies but is **not itself a discrete molecular target, receptor, enzyme, or transporter**, making “Plasmodium falciparum heme/iron-dependent activation leading to free radical formation” an incorrect or non-canonical therapeutic target designation. This is a process essential for the effectiveness of several antimalarial drugs and is also implicated in drug resistance when the parasite modulates hemoglobin uptake or heme metabolism[1][3][5][7][8]. **Key caveat**: The term does not correspond to a defined molecular entity (protein, receptor, or enzyme), but to a parasite-intrinsic biochemical pathway crucial to antimalarial drug action—entries for specific hemoglobinases, heme transporters, or the artemisinin-activated proteins would be canonical.

Other names

Iron-dependent activation in Plasmodium falciparumArtemisinin heme activation site in PlasmodiumHeme-iron mediated free radical formation in Plasmodium

Bioactivation of artemisinin (and derivatives) by heme/iron to generate cytotoxic free radicals Inhibition of hemozoin (hematin) formation, resulting in toxic free heme accumulation Induction of oxidative damage to parasite proteins and membranes